Most sold healthcare stocks in Q3 2019

See which Healthcare stocks institutional investors trimmed or exited the most in Q3 2019, measured as net reductions in reported share positions from Q2 2019 into Q3 2019. Notable reductions at the top of this list include AVANTOR INC (AVTR), BAXTER INTERNATIONAL INC (BAX), DANAHER CORP (DHR), MODERNA INC (MRNA). These rankings are based on SEC 13F filings from the investors we track.

SymbolNameNet sharesNet valueNewAddedTrimmedSold outHolding now
AVTRAVANTOR INC-7,859,958-$184.61K00111
BAXBAXTER INTERNATIONAL INC-6,156,984-$406.34K00205
DHRDANAHER CORP-4,514,021-$629.51K01307
MRNAMODERNA INC-3,801,477-$49.67K00111
MCKMCKESSON CORP-2,351,172-$297.35K02315
DVADAVITA INC-2,261,937-$95.40K10013
IQVIQVIA HOLDINGS INC-2,214,665-$446.14K02204
LLYELI LILLY & CO-2,142,108-$227.23K02204
NVSNOVARTIS AG-SPONSORED ADR-1,539,581-$397.81K02308
SAVACASSAVA SCIENCES INC-1,527,015-$1.99K01011
UNHUNITEDHEALTH GROUP INC-1,434,094-$902.32K374214
AZNASTRAZENECA PLC-SPONS ADR-1,241,859$111.58K01102
CORCENCORA INC-1,047,510-$102.87K01103
HALOHALOZYME THERAPEUTICS INC-949,290-$16.86K01113
VCYTVERACYTE INC-775,855-$34.69K00202
EHCENCOMPASS HEALTH CORP-742,168-$47.05K01102
ZBHZIMMER BIOMET HOLDINGS INC-731,596-$34.09K00515
PFEPFIZER INC-713,565-$5.96M04529
SYKSTRYKER CORP-592,015-$41.86K12316
SGMOSANGAMO THERAPEUTICS INC-559,800-$6.14K00101
WATWATERS CORP-508,919-$65.36K01203
HSICHENRY SCHEIN INC-486,100-$35.17K00101
PHGKONINKLIJKE PHILIPS NVR- NY-474,248-$20.56K00011
RVNCREVANCE THERAPEUTICS INC-454,600-$5.87K00101
HBIOHARVARD BIOSCIENCE INC-385,788-$21800101
EBSEMERGENT BIOSOLUTIONS INC-366,200-$13.78K00101
RGNXREGENXBIO INC-350,441-$18.00K00010
OSURORASURE TECHNOLOGIES INC-349,700-$11.60K00101
WBAWALGREENS BOOTS ALLIANCE INC-334,985-$18.20K01113
NKTRNEKTAR THERAPEUTICS-327,048-$11.64K00010
GOSSGOSSAMER BIO INC-300,000-$11.39K00101
CYTKCYTOKINETICS INC-298,000-$3.34K00101
CPIXCUMBERLAND PHARMACEUTICALS-295,224-$2.51K01102
PETSPETMED EXPRESS INC-292,715-$77500101
PDCOPATTERSON COS INC-284,522-$9.68K00202
BLFSBIOLIFE SOLUTIONS INC-282,878-$4.97K00111
HCSGHEALTHCARE SERVICES GROUP-273,981-$10.21K01021
PBYIPUMA BIOTECHNOLOGY INC-252,200-$3.21K00010
AXSMAXSOME THERAPEUTICS INC-247,200-$6.37K00010
DXCMDEXCOM INC-245,543-$36.83K00101
PTCTPTC THERAPEUTICS INC-238,760-$12.20K00101
ANABANAPTYSBIO INC-223,692-$24.97K00101
HQYHEALTHEQUITY INC-214,291-$21.84K00101
SNNSMITH & NEPHEW PLC -SPON ADR-206,850-$9.01K00010
ARAYACCURAY INC-206,391-$6.18K00101
BRKRBRUKER CORP-202,910-$10.13K00010
STAASTAAR SURGICAL CO-191,600-$5.63K00010
DVAXDYNAVAX TECHNOLOGIES CORP-187,251-$74700010
CRLCHARLES RIVER LABORATORIES-181,727-$47.69K01102
IDXXIDEXX LABORATORIES INC-179,926-$67.18K01205
20 symbols with net change in reported shares from tracked managers.−8.6M−6.5M−4.3M−2.2M0.00Net change in reported shares (tracked managers)AVTRBAXDHRMRNAMCKDVAIQVLLYNVSSAVAUNHAZNCORHALOVCYTEHCZBHPFESYKSGMOSymbol

Frequently asked questions about Most sold healthcare stocks in Q3 2019

  • What are the most sold Healthcare stocks in Q3 2019?

    The most sold healthcare stocks in Q3 2019 are those with the largest decrease in reported share counts across tracked institutional investors compared to Q2 2019, based on SEC 13F filings.

  • Which healthcare stocks did institutional investors trimmed or exited the most in Q3 2019?

    Among the managers we track, net reductions were largest in companies such as AVANTOR INC (AVTR), BAXTER INTERNATIONAL INC (BAX), DANAHER CORP (DHR), based on aggregated 13F data.

  • How is institutional selling calculated?

    Selling is calculated by summing the net decrease in shares reported by tracked investors between two consecutive quarterly 13F snapshots (compared to Q2 2019).

  • Does this include all institutional owners?

    These rankings are based on a subset of tracked institutional investors who file SEC 13F reports. While not exhaustive, the dataset includes many of the largest and most influential funds.

  • Are these trades real-time?

    No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.